Form D · Pharmaceuticals

QUATRX PHARMACEUTICALS Co

Ann Arbor, MI · CIK 0001166029

Offering snapshot reported Apr 24, 2009 · SEC filing

Reported sold
$14M
Offering amount: $37.1M
Investors reported
Not reported
Form D · investor count
Minimum accepted
Not reported
Reported outside-investor minimum
First sale
Not reported
As reported in this filing

What changed?

Latest filing versus its linked predecessor, where available.

No comparable changes in the displayed metrics.

Filing history

Scroll to see all columns →

FiledFiling typeReported soldChange vs linked filingInvestorsSource
Apr 24, 2009Initial$14,025,045No comparisonNot reportedSEC filing
Dec 24, 2008PaperNot reportedNo comparisonNot reportedSEC filing
Nov 25, 2008PaperNot reportedNo comparisonNot reportedSEC filing
May 25, 2007PaperNot reportedNo comparisonNot reportedSEC filing
Oct 31, 2005PaperNot reportedNo comparisonNot reportedSEC filing

Offering details

Securities
Not reported
Exemptions
Not reported
Duration over one year
Not reported
Business combination
Not reported
Sales commissions
Not reported
Finders' fees
Not reported
Form D file number
021-39151

Source: Form D, filed Apr 24, 2009. Minimum accepted may differ from a standard advertised minimum.

Fund connections

No confirmed ADV fund connection is available for this issuer.

People & organizations

Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.

People and organizations reported in Form D filings
NameReported role
Jeffery M Brinza Executive
Stuart Dombey Executive
Chris Ehrlich Director
Rick Fox Director
Patrick Heron Director
Anders Hove Director
Chris Moller Director
Christopher Nicholas Executive
Gary Onn Executive
Nick Simon Director
August Watanabe Director
Anders Wiklund Director
Robert L Zerbe Executive

Issuer details

Industry: Pharmaceuticals (See others in industry)

Address:
777 East Eisenhower Parkway Suite 100
Ann Arbor, MI, 48108